Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus

Advances in Virology

Volumn 2013, Issue , 2013, Pages

  Bawage, Swapnil Subhash ^a   Tiwari, Pooja Munnilal ^a   Pillai, Shreekumar ^a   Dennis, Vida ^a   Singh, Shree Ram ^a  

^a ALABAMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893724739     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2013/595768     Document Type: Review

References (224)

1. Nair H., Simões E. A. F., Rudan I., Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. The Lancet 2013 381 1380 1390
2. Bloom-Feshbach K., Alonso W. J., Charu V., Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS ONE 2013 8 2 e54445
3. Henrickson H., Cost-effective use of rapid diagnostic techniques in the treatment and prevention of viral respiratory infections. Pediatric Annals 2005 34 1 24 31 2-s2.0-12344298659
4. Krilov L. R., Respiratory syncytial virus disease: update on treatment and prevention. Expert Review of Anti-Infective Therapy 2011 9 1 27 32 2-s2.0-78650656135 10.1586/eri.10.140
5. Galindo-Fraga A., Ortiz-Hernández A. A., Ramírez-Venegas A., Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico city. International Journal of Infectious Diseases 2013 17 7 510 517
6. Tran D. N., Pham T. M. H., Ha M. T., Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam. PLoS ONE 2013 8 1 e45436
7. Collins P. L., Allan G., Robert G. W., Respiratory syncytial virus-human (Paramyxoviridae). Encyclopedia of Virology 1999 2nd Oxford, UK Elsevier 1479 1487
8. Hacking D., Hull J., Respiratory syncytial virus-viral biology and the host response. Journal of Infection 2002 45 1 18 24 2-s2.0-0036665073 10.1053/jinf.2002.1015 (Pubitemid 36104802)
9. Ogra P. L., Respiratory syncytial virus: the virus, the disease and the immune response. Paediatric Respiratory Reviews 2004 5 S119 S126 2-s2.0-1342329509 10.1016/S1526-0542(04)90023-1
10. Costello H. M., Ray W. C., Chaiwatpongsakorn S., Peeples M. E., Targeting RSV with vaccines and small molecule drugs. Infectious Disorders 2012 12 2 110 128 2-s2.0-84860306713
11. Zhao X., Singh M., Malashkevich V. N., Kim P. S., Structural characterization of the human respiratory syncytial virus fusion protein core. Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14172 14177 2-s2.0-0034687711 10.1073/pnas.260499197 (Pubitemid 32016549)
12. Collins P. L., Graham B. S., Viral and host factors in human respiratory syncytial virus pathogenesis. Journal of Virology 2008 82 5 2040 2055 2-s2.0-39749139538 10.1128/JVI.01625-07 (Pubitemid 351293507)
13. Kasper D. L., Harrison's Principles of Internal Medicine 2005 McGraw-Hill
14. Langley J. M., LeBlanc J. C., Wang E. E. L., Law B. J., MacDonald N. E., Mitchell I., Stephens D., McDonald J., Boucher F. D., Dobson S., Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a pediatric investigators collaborative network on infections in Canada study. Pediatrics 1997 100 6 943 946 2-s2.0-0030722560 (Pubitemid 27516477)
15. Simon A., Müller A., Khurana K., Engelhart S., Exner M., Schildgen O., Eis-Hübinger A. M., Kamin W., Schaible T., Wadas K., Ammann R. A., Wilkesmann A., Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection-results from a prospective multicenter German surveillance study. International Journal of Hygiene and Environmental Health 2008 211 3-4 241 250 2-s2.0-45349096928 10.1016/j.ijheh.2007.07.020 (Pubitemid 351847846)
16. Falsey A. R., Hennessey P. A., Formica M. A., Cox C., Walsh E. E., Respiratory syncytial virus infection in elderly and high-risk adults. The New England Journal of Medicine 2005 352 17 1749 1759 2-s2.0-17644392071 10.1056/NEJMoa043951 (Pubitemid 40570923)
17. Singleton R., Etchart N., Hou S., Hyland L., Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses. Journal of Virology 2003 77 21 11303 11311 2-s2.0-0142060905 10.1128/JVI.77.21.11303-11311. 2003 (Pubitemid 37271629)
18. Pockett R. D., Campbell D., Carroll S., Rajoriya F., Adlard N., Rotavirus, respiratory syncytial virus and non-rotaviral gastroenteritis analysis of hospital readmissions in England and Wales. Acta Paediatrica 2013 102 4 e158 e163
19. Falsey A. R., Respiratory syncytial virus: a global pathogen in an aging world. Clinical Infectious Diseases 2013 57 8 1078 1080 10.1093/cid/cit473
20. Hall C. B., Respiratory syncytial virus and parainfluenza virus. The New England Journal of Medicine 2001 344 25 1917 1928 2-s2.0-0035927982 10.1056/NEJM200106213442507 (Pubitemid 32553362)
21. Rebuffo-Scheer C., Bose M., He J., Khaja S., Ulatowski M., Beck E. T., Fan J., Kumar S., Nelson M. I., Henrickson K. J., Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. PLoS ONE 2011 6 10 2-s2.0-80053593773 10.1371/journal.pone.0025468 e25468
22. Khor C. S., Sam I. C., Hooi P. S., Chan Y. F., Displacement of predominant respiratory syncytial virus genotypes in Malaysia between 1989 and 2011. Infection, Genetics and Evolution 2013 14 357 360
23. Svraka S., Rosario K., Duizer E., Van Der Avoort H., Breitbart M., Koopmans M., Metagenomic sequencing for virus identification in a public-health setting. Journal of General Virology 2010 91 11 2846 2856 2-s2.0-78049386423 10.1099/vir.0.024612-0
24. Shafik C. F., Mohareb E. W., Youssef F. G., Comparison of direct fluorescence assay and real-time RT-PCR as diagnostics for respiratory syncytial virus in young children. Journal of Tropical Medicine 2011 2011 3 2-s2.0-84855611827 10.1155/2011/781919 781919
25. Landry M. L., Ferguson D., SimulFluor respiratory screen for rapid detection of multiple respiratory viruses in clinical specimens by immunofluorescence staining. Journal of Clinical Microbiology 2000 38 2 708 711 2-s2.0-0033967884 (Pubitemid 30082667)
26. Agrawal A., Tripp R. A., Anderson L. J., Nie S., Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes. Journal of Virology 2005 79 13 8625 8628 2-s2.0-20744451524 10.1128/JVI.79.13.8625-8628.2005 (Pubitemid 40853562)
27. Chattopadhyay P. K., Price D. A., Harper T. F., Betts M. R., Yu J., Gostick E., Perfetto S. P., Goepfert P., Koup R. A., De Rosa S. C., Bruchez M. P., Roederer M., Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nature Medicine 2006 12 8 972 977 2-s2.0-33746788900 10.1038/nm1371 (Pubitemid 44175152)
28. Tripp R. A., Alvarez R., Anderson B., Jones L., Weeks C., Chen W., Bioconjugated nanoparticle detection of respiratory syncytial virus infection. International Journal of Nanomedicine 2007 2 1 117 124 (Pubitemid 46901788)
29. Bentzen E. L., House F., Utley T. J., Crowe J. E. Jr., Wright D. W., Progression of respiratory syncytial virus infection monitored by fluorescent quantum dot probes. Nano Letters 2005 5 4 591 595 2-s2.0-18144401308 10.1021/nl048073u (Pubitemid 40609725)
30. Mattanovich D., Borth N., Applications of cell sorting in biotechnology. Microbial Cell Factories 2006 5, article 12 2-s2.0-33645774926 10.1186/1475-2859-5-12
31. Chen M., Chang J. S., Nason M., Rangel D., Gall J. G., Graham B. S., Ledgerwood J. E., A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate. Journal of Immunological Methods 2010 362 1-2 180 184 2-s2.0-77958456819 10.1016/j.jim.2010.08.005
32. Santangelo P. J., Nix B., Tsourkas A., Bao G., Dual FRET molecular beacons for mRNA detection in living cells. Nucleic Acids Research 2004 32 6, article e57 2-s2.0-3843132105
33. Jayagopal A., Halfpenny K. C., Perez J. W., Wright D. W., Hairpin DNA-functionalized gold colloids for the imaging of mRNA in live cells. Journal of the American Chemical Society 2010 132 28 9789 9796 2-s2.0-77954630013 10.1021/ja102585v
34. Centre for Drug Evaluation and Research, Division of Anti-Viral Products Advisory Committee Briefing document, FDA, 2010
35. Rochelet M., Solanas S., Grossiord C., A thin layer-based amperometric enzyme immunoassay for the rapid and sensitive diagnosis of respiratory syncytial virus infections. Talanta 2012 100 139 144
36. von Lode P., Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. Clinical Biochemistry 2005 38 7 591 606 2-s2.0-21844471002 10.1016/j.clinbiochem.2005.03.008 (Pubitemid 40961628)
37. Harbeck R. J., Teague J., Crossen G. R., Maul D. M., Childers P. L., Novel, rapid optical immunoassay technique for detection of group A streptococci from pharyngeal specimens: comparison with standard culture methods. Journal of Clinical Microbiology 1993 31 4 839 844 2-s2.0-0027513387 (Pubitemid 23086525)
38. Aldous W. K., Gerber K., Taggart E. W., Rupp J., Wintch J., Daly J. A., A comparison of Thermo Electron RSV OIA to viral culture and direct fluorescent assay testing for respiratory syncytial virus. Journal of Clinical Virology 2005 32 3 224 228 2-s2.0-13844299183 10.1016/j.jcv.2004.07.010 (Pubitemid 40255090)
39. Slinger R., Milk R., Gaboury I., Diaz-Mitoma F., Evaluation of the QuickLab RSV test, a new rapid lateral-flow immunoassay for detection of respiratory syncytial virus antigen. Journal of Clinical Microbiology 2004 42 8 3731 3733 2-s2.0-3843061328 10.1128/JCM.42.8.3731-3733.2004 (Pubitemid 39045705)
40. Gregson D., Lloyd T., Buchan S., Church D., Comparison of the RSV Respi-Strip with direct fluorescent-antigen detection for diagnosis of respiratory syncytial virus infection in pediatric patients. Journal of Clinical Microbiology 2005 43 11 5782 5783 2-s2.0-27744436945 10.1128/JCM.43.11.5782- 5783.2005 (Pubitemid 41612363)
41. Borek A. P., Clemens S. H., Gaskins V. K., Aird D. Z., Valsamakis A., Respiratory syncytial virus detection by remel Xpect, Binax Now RSV, direct immunofluorescent staining, and tissue culture. Journal of Clinical Microbiology 2006 44 3 1105 1107 2-s2.0-33644919701 10.1128/JCM.44.3.1105-1107.2006
42. Selvarangan R., Abel D., Hamilton M., Comparison of BD Directigen EZ RSV and Binax NOW RSV tests for rapid detection of respiratory syncytial virus from nasopharyngeal aspirates in a pediatric population. Diagnostic Microbiology and Infectious Disease 2008 62 2 157 161 2-s2.0-51649108024 10.1016/j.diagmicrobio. 2008.05.005
43. Shirato K., Nishimura H., Saijo M., Okamoto M., Noda M., Tashiro M., Taguchi F., Diagnosis of human respiratory syncytial virus infection using reverse transcription loop-mediated isothermal amplification. Journal of Virological Methods 2007 139 1 78 84 2-s2.0-33845199748 10.1016/j.jviromet.2006. 09.014 (Pubitemid 44854228)
44. Wang X., Zhang Q., Zhang F., Visual detection of the human metapneumovirus using reverse transcription loop-mediated isothermal amplification with hydroxynaphthol blue dye. Virology Journal 2012 9, article 138
45. Mahony J., Chong S., Bulir D., Ruyter A., Mwawasi K., Waltho D., Development of a sensitive loop-mediated isothermal amplification (LAMP) assay providing specimen-to-result diagnosis of RSV infections in thirty minutes. Journal of Clinical Microbiology 2013 51 8 2696 2701 10.1128/JCM.00662-13
46. Jartti T., Söderlund-Venermo M., Hedman K., Ruuskanen O., Mäkelä M. J., New molecular virus detection methods and their clinical value in lower respiratory tract infections in children. Paediatric Respiratory Reviews 2013 14 1 38 45 2-s2.0-84860593968 10.1016/j.prrv.2012.04.002
47. Falsey A. R., Formica M. A., Walsh E. E., Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. Journal of Clinical Microbiology 2002 40 3 817 820 2-s2.0-0036196503 10.1128/JCM.40.3.817-820.2002 (Pubitemid 34208629)
48. Hu A., Colella M., Tam J. S., Rappaport R., Cheng S.-M., Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. Journal of Clinical Microbiology 2003 41 1 149 154 2-s2.0-0037232155 10.1128/JCM.41.1.149-154.2003 (Pubitemid 36098568)
49. Dewhurst-Maridor G., Simonet V., Bornand J. E., Nicod L. P., Pache J. C., Development of a quantitative TaqMan RT-PCR for respiratory syncytial virus. Journal of Virological Methods 2004 120 1 41 49 2-s2.0-3242805085 10.1016/j.jviromet.2004.03.017 (Pubitemid 38968655)
50. Gueudin M., Vabret A., Petitjean J., Gouarin S., Brouard J., Freymuth F., Quantitation of respiratory syncytial virus RNA in nasal aspirates of children by real-time RT-PCR assay. Journal of Virological Methods 2003 109 1 39 45 2-s2.0-0037379078 10.1016/S0166-0934(03)00042-9 (Pubitemid 36349709)
51. Mentel R., Wegner U., Bruns R., Gürtler L., Real-time PCR to improve the diagnosis of respiratory syncytial virus infection. Journal of Medical Microbiology 2003 52 10 893 896 2-s2.0-0142061562 10.1099/jmm.0.05290-0 (Pubitemid 37297319)
52. van Elden L. J. R., van Loon A. M., van der Beek A., Hendriksen K. A. W., Hoepelman A. I. M., Van Kraaij M. G. J., Schipper P., Nijhuis M., Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults. Journal of Clinical Microbiology 2003 41 9 4378 4381 2-s2.0-0042921112 10.1128/JCM.41.9.4378-4381.2003 (Pubitemid 37099710)
53. Kuypers J., Wright N., Morrow R., Evaluation of quantitative and type-specific real-time RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from children. Journal of Clinical Virology 2004 31 2 123 129 2-s2.0-4444326240 10.1016/j.jcv.2004.03.018 (Pubitemid 39208951)
54. Chi X. S., Li F., Tam J. S., Rappaport R., Cheng S.-M., Semiquantitative one-step RT-PCR for simultaneous identification of human influenza and respiratory syncytial viruses. Journal of Virological Methods 2007 139 1 90 92 2-s2.0-33845218332 10.1016/j.jviromet.2006.08.015 (Pubitemid 44854217)
55. Choudhary M. L., Anand S. P., Heydari M., Development of a multiplex one step RT-PCR that detects eighteen respiratory viruses in clinical specimens and comparison with real time RT-PCR. Journal of Virological Methods 2013 189 1 15 19
56. Alby K., Popowitch E. B., Miller M. B., Comparative evaluation of the Nanosphere Verigene RV+ assay with the Simplexa Flu A/B & RSV Kit for the detection of influenza and respiratory syncytial viruses. Journal of Clinical Microbiology 2012 51 1 352 353
57. Xu M., Qin X., Astion M. L., Implementation of FilmArray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. American Journal of Clinical Pathology 2013 139 1 118 123
58. Niemeyer C. M., Adler M., Wacker R., Immuno-PCR: high sensitivity detection of proteins by nucleic acid amplification. Trends in Biotechnology 2005 23 4 208 216 2-s2.0-15044351755 10.1016/j.tibtech.2005.02.006 (Pubitemid 40381284)
59. Perez J. W., Vargis E. A., Russ P. K., Haselton F. R., Wright D. W., Detection of respiratory syncytial virus using nanoparticle amplified immuno-polymerase chain reaction. Analytical Biochemistry 2011 410 1 141 148 2-s2.0-78651375475 10.1016/j.ab.2010.11.033
60. Heller M. J., DNA microarray technology: devices, systems, and applications. Annual Review of Biomedical Engineering 2002 4 129 153 2-s2.0-0036405278 10.1146/annurev.bioeng.4.020702.153438 (Pubitemid 35217417)
61. Djikeng A., Halpin R., Kuzmickas R., DePasse J., Feldblyum J., Sengamalay N., Afonso C., Zhang X., Anderson N. G., Ghedin E., Spiro D. J., Viral genome sequencing by random priming methods. BMC Genomics 2008 9, article 5 2-s2.0-39849084772 10.1186/1471-2164-9-5 (Pubitemid 351315033)
62. Wang D., Coscoy L., Zylberberg M., Avila P. C., Boushey H. A., Ganem D., DeRisi J. L., Microarray-based detection and genotyping of viral pathogens. Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15687 15692 2-s2.0-18744377158 10.1073/pnas.242579699 (Pubitemid 35403992)
63. Chiu C. Y., Urisman A., Greenhow T. L., Rouskin S., Yagi S., Schnurr D., Wright C., Drew W. L., Wang D., Weintrub P. S., DeRisi J. L., Ganem D., Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children. Journal of Pediatrics 2008 153 1 76 83 2-s2.0-47649120745 10.1016/j.jpeds.2007.12.035
64. Greninger A. L., Chen E. C., Sittler T., Scheinerman A., Roubinian N., Yu G., Kim E., Pillai D. R., Guyard C., Mazzulli T., Isa P., Arias C. F., Hackett J. Jr., Schochetman G., Miller S., Tang P., Chiu C. Y., A metagenomic analysis of pandemic influenza a (2009 H1N1) infection in patients from North America. PLoS ONE 2010 5 10 2-s2.0-78149461455 10.1371/journal.pone.0013381 e13381
65. Townsend M. B., Dawson E. D., Mehlmann M., Smagala J. A., Dankbar D. M., Moore C. L., Smith C. B., Cox N. J., Kuchta R. D., Rowlen K. L., Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance. Journal of Clinical Microbiology 2006 44 8 2863 2871 2-s2.0-33747151669 10.1128/JCM.00134-06 (Pubitemid 44228582)
66. Chen E. C., Miller S. A., Derisi J. L., Chiu C. Y., Using a pan-viral microarray assay (virochip) to screen clinical samples for viral pathogens. Journal of Visualized Experiments 2011 27 50 2-s2.0-80355149025 10.3791/2536 e2536
67. Wong C. W., Heng C. L. W., Wan Yee L., Soh S. W. L., Kartasasmita C. B., Simoes E. A. F., Hibberd M. L., Sung W.-K., Miller L. D., Optimization and clinical validation of a pathogen detection microarray. Genome Biology 2007 8 5, article R93 2-s2.0-34548838602 10.1186/gb-2007-8-5-r93 (Pubitemid 351895136)
68. Huang Y. C. T., Li Z., Hyseni X., Schmitt M., Devlin R. B., Karoly E. D., Soukup J. M., Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line. Genomic Medicine 2008 2 3-4 113 125 2-s2.0-68049118559 10.1007/s11568-009-9080-y
69. Janssen R., Pennings J., Hodemaekers H., Buisman A., Van Oosten M., De Rond L., Öztürk K., Dormans J., Kimman T., Hoebee B., Host transcription profiles upon primary respiratory syncytial virus infection. Journal of Virology 2007 81 11 5958 5967 2-s2.0-34249776370 10.1128/JVI.02220-06 (Pubitemid 46847032)
70. Bacharier L. B., Cohen R., Schweiger T., Yin-DeClue H., Christie C., Zheng J., Schechtman K. B., Strunk R. C., Castro M., Determinants of asthma after severe respiratory syncytial virus bronchiolitis. Journal of Allergy and Clinical Immunology 2012 130 1 91 100 2-s2.0-84858607150 10.1016/j.jaci.2012.02. 010
71. Krishnamoorthy N., Khare A., Oriss T. B., Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nature Medicine 2012 18 10 1525 1530
72. Yu X., Schneiderhan-Marra N., Joos T. O., Protein microarrays for personalized medicine. Clinical Chemistry 2010 56 3 376 387 2-s2.0-77649194471 10.1373/clinchem.2009.137158
73. Zhu H., Hu S., Jona G., Zhu X., Kreiswirth N., Willey B. M., Mazzulli T., Liu G., Song Q., Chen P., Cameron M., Tyler A., Wang J., Wen J., Chen W., Compton S., Snyder M., Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proceedings of the National Academy of Sciences of the United States of America 2006 103 11 4011 4016 2-s2.0-33645225281 10.1073/pnas.0510921103
74. Yang L., Guo S., Li Y., Zhou S., Tao S., Protein microarrays for systems biology. Acta Biochimica et Biophysica Sinica 2011 43 3 161 171 2-s2.0-79951878064 10.1093/abbs/gmq127
75. Sampath R., Russell K. L., Massire C., Global surveillance of emerging Influenza virus genotypes by mass spectrometry. PLoS ONE 2007 2 5, article e489
76. Chen K. F., Blyn L., Rothman R. E., Ramachandran P., Valsamakis A., Ecker D., Sampath R., Gaydos C. A., Reverse transcription polymerase chain reaction and electrospray ionization mass spectrometry for identifying acute viral upper respiratory tract infections. Diagnostic Microbiology and Infectious Disease 2011 69 2 179 186 2-s2.0-78651465649 10.1016/j.diagmicrobio.2010.10.010
77. Demirel M. C., Kao S., Malvadkar N., Wang H., Gong X., Poss M., Allara D. L., Bio-organism sensing via surface enhanced Raman spectroscopy on controlled metal/polymer nanostructured substrates. Biointerphases 2009 4 2 35 41 2-s2.0-70249132209 10.1116/1.3147962
78. Tripp R. A., Dluhy R. A., Zhao Y., Novel nanostructures for SERS biosensing. Nano Today 2008 3 3-4 31 37 2-s2.0-44649172607 10.1016/S1748- 0132(08)70042-2 (Pubitemid 351781282)
79. Hudson S. D., Chumanov G., Bioanalytical applications of SERS (surface-enhanced Raman spectroscopy). Analytical and Bioanalytical Chemistry 2009 394 3 679 686 2-s2.0-67349251900 10.1007/s00216-009-2756-2
80. Liu H., Zhang L., Lang X., Yamaguchi Y., Iwasaki H., Inouye Y., Xue Q., Chen M., Single molecule detection from a large-scale SERS-active Au79Ag21 substrate. Scientific Reports 2011 1, article 112 2-s2.0-84859760176 10.1038/srep00112
81. Benevides J. M., Overman S. A., Thomas G. J. Jr., Raman, polarized Raman and ultraviolet resonance Raman spectroscopy of nucleic acids and their complexes. Journal of Raman Spectroscopy 2005 36 4 279 299 2-s2.0-18444405871 10.1002/jrs.1324 (Pubitemid 40653526)
82. Hennigan S. L., Driskell J. D., Dluhy R. A., Zhao Y., Tripp R. A., Waites K. B., Krause D. C., Detection of Mycoplasma pneumoniaein simulated and true clinical throat swab specimens by nanorod array-surface-enhanced raman spectroscopy. PLoS ONE 2010 5 10 2-s2.0-78149431196 10.1371/journal.pone.0013633 e13633
83. Driskell J. D., Zhu Y., Kirkwood C. D., Zhao Y., Dluhy R. A., Tripp R. A., Rapid and sensitive detection of rotavirus molecular signatures using surface enhanced raman spectroscopy. PLoS ONE 2010 5 4 2-s2.0-77956331568 10.1371/journal.pone.0010222 e10222
84. Shanmukh S., Jones L., Zhao Y.-P., Driskell J. D., Tripp R. A., Dluhy R. A., Identification and classification of respiratory syncytial virus (RSV) strains by surface-enhanced Raman spectroscopy and multivariate statistical techniques. Analytical and Bioanalytical Chemistry 2008 390 6 1551 1555 2-s2.0-41149172191 10.1007/s00216-008-1851-0
85. McGivney J. B., Bishop E., Miller K., Casas-Finet J., Yang H., Wei Z., Strouse R., Schenerman M., Evaluation of a synthetic peptide as a replacement for the recombinant fusion protein of respiratory syncytial virus in a potency ELISA. Journal of Pharmaceutical and Biomedical Analysis 2011 54 3 572 576 2-s2.0-78149501024 10.1016/j.jpba.2010.09.008
86. Siuzdak G., Probing viruses with mass spectrometry. Journal of Mass Spectrometry 1998 33 3 203 211
87. Bothner B., Siuzdak G., Electrospray ionization of a whole virus: analyzing mass, structure, and viability. ChemBioChem 2004 5 3 258 260 2-s2.0-4544232304 10.1002/cbic.200300754 (Pubitemid 39257116)
88. Aebersold R., Mann M., Mass spectrometry-based proteomics. Nature 2003 422 6928 198 207 2-s2.0-0037435030 10.1038/nature01511 (Pubitemid 36362757)
89. Ho Y. P., Muralidhar Reddy P., Identification of pathogens by mass spectrometry. Clinical Chemistry 2010 56 4 525 536 2-s2.0-77950549715 10.1373/clinchem.2009.138867
90. Chou T. C., Hsu W., Wang C.-H., Chen Y.-J., Fang J.-M., Rapid and specific influenza virus detection by functionalized magnetic nanoparticles and mass spectrometry. Journal of Nanobiotechnology 2011 9, article 52 2-s2.0-81055127548 10.1186/1477-3155-9-52
91. Yao Z. P., Demirev P. A., Fenselau C., Mass spectrometry-based proteolytic mapping for rapid virus identification. Analytical Chemistry 2002 74 11 2529 2534 2-s2.0-0036606429 10.1021/ac0200217 (Pubitemid 34602523)
92. Caliendo A. M., Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clinical Infectious Diseases 2011 52 4 S326 S330 2-s2.0-79953785400 10.1093/cid/cir047
93. Sampath R., Mulholland N., Blyn L. B., Comprehensive biothreat cluster identification by PCR/electrospray-ionization mass spectrometry. PLoS ONE 2012 7 6 e36528
94. Casiano-Colón A. E., Hulbert B. B., Mayer T. K., Walsh E. E., Falsey A. R., Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. Journal of Clinical Virology 2003 28 2 169 174 2-s2.0-0041883263 10.1016/S1386-6532(03)00002-7 (Pubitemid 37040869)
95. Shetty A. K., Treynor E., Hill D. W., Gutierrez K. M., Warford A., Baron E. J., Comparison of conventional viral cultures with direct fluorescent antibody stains for diagnosis of community-acquired respiratory virus infections in hospitalized children. The Pediatric Infectious Disease Journal 2003 22 9 789 794 2-s2.0-0141459350 10.1097/01.inf.0000083823.43526.97 (Pubitemid 37153072)
96. Aslanzadeh J., Zheng X., Li H., Tetreault J., Ratkiewicz I., Meng S., Hamilton P., Tang Y.-W., Prospective evaluation of rapid antigen tests for diagnosis of respiratory syncytial virus and human metapneumovirus infections. Journal of Clinical Microbiology 2008 46 5 1682 1685 2-s2.0-43249109381 10.1128/JCM.00008-08 (Pubitemid 351657214)
97. Ali S. A., Gern J. E., Hartert T. V., Real-world comparison of two molecular methods for detection of respiratory viruses. Virology Journal 2011 8, article 332
98. Jannetto P. J., Buchan B. W., Vaughan K. A., Ledford J. S., Anderson D. K., Henley D. C., Quigley N. B., Ledeboer N. A., Real-time detection of influenza A, influenza B, and respiratory syncytial virus A and B in respiratory specimens by use of nanoparticle probes. Journal of Clinical Microbiology 2010 48 11 3997 4002 2-s2.0-78049514476 10.1128/JCM.01118-10
99. Thaxton C. S., Georganopoulou D. G., Mirkin C. A., Gold nanoparticle probes for the detection of nucleic acid targets. Clinica Chimica Acta 2006 363 1-2 120 126 2-s2.0-28544432587 10.1016/j.cccn.2005.05.042 (Pubitemid 41745229)
100. Hall C. B., Douglas R. G. Jr., Modes of transmission of respiratory syncytial virus. Journal of Pediatrics 1981 99 1 100 103 2-s2.0-0019829501 (Pubitemid 11046430)
101. Ottolini M. G., Curtis S. R., Mathews A., Ottolini S. R., Prince G. A., Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model. Bone Marrow Transplantation 2002 29 2 117 120 2-s2.0-0036172185 10.1038/sj/bmt/1703326 (Pubitemid 34144843)
102. Huang K., Incognito L., Cheng X., Ulbrandt N. D., Wu H., Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion. Journal of Virology 2010 84 16 8132 8140 2-s2.0-77954995414 10.1128/JVI.02699-09
103. Harkensee C., Brodlie M., Embleton N. D., Mckean M., Passive immunisation of preterm infants with palivizumab against RSV infection. Journal of Infection 2006 52 1 2 8 2-s2.0-30944441090 10.1016/j.jinf.2005.08.003 (Pubitemid 43115501)
104. Committee on Infectious Diseases, Modified recommendations for use of Palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009 124 6 1694 1701
105. Zeitlin L., Bohorov O., Bohorova N., Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs 2013 5 2 263 269
106. Li X., Sambhara S., Li C. X., Ettorre L., Switzer I., Cates G., James O., Parrington M., Oomen R., Du R.-P., Klein M., Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate. Virology 2000 269 1 54 65 2-s2.0-0034732137 10.1006/viro.2000.0186 (Pubitemid 30183169)
107. Li X., Sambhara S., Li C. X., Ewasyshyn M., Parrington M., Caterini J., James O., Cates G., Du R.-P., Klein M., Protection against respiratory syncytial virus infection by DNA immunization. The Journal of Experimental Medicine 1998 188 4 681 688 2-s2.0-18344410538 10.1084/jem.188.4.681 (Pubitemid 28387931)
108. Ternette N., Tippler B., Überla K., Grunwald T., Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus. Vaccine 2007 25 41 7271 7279 2-s2.0-34648840508 10.1016/j.vaccine.2007.07.025 (Pubitemid 47464663)
109. Martinez-Sobrido L., Gitiban N., Fernandez-Sesma A., Cros J., Mertz S. E., Jewell N. A., Hammond S., Flano E., Durbin R. K., García-Sastre A., Durbin J. E., Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. Journal of Virology 2006 80 3 1130 1139 2-s2.0-31144460062 10.1128/JVI.80.3.1130-1139.2006 (Pubitemid 43134070)
110. Wu H., Dennis V. A., Pillai S. R., Singh S. R., RSV fusion (F) protein DNA vaccine provides partial protection against viral infection. Virus Research 2009 145 1 39 47 2-s2.0-69449097073 10.1016/j.virusres.2009.06.012
111. Talaat A. M., Lyons R., Johnston S. A., A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses. Vaccine 2001 20 3-4 538 544 2-s2.0-0035851350 10.1016/S0264-410X(01)00352-8 (Pubitemid 32973799)
112. Bueno S. M., González P. A., Cautivo K. M., Mora J. E., Leiva E. D., Tobar H. E., Fennelly G. J., Eugenin E. A., Jacobs W. R. Jr., Riedel C. A., Kalergis A. M., Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proceedings of the National Academy of Sciences of the United States of America 2008 105 52 20822 20827 2-s2.0-58549103296 10.1073/pnas.0806244105
113. Xie C., He J. S., Zhang M., Xue S.-L., Wu Q., Ding X.-D., Song W., Yuan Y., Li D.-L., Zheng X.-X., Lu Y.-Y., Shang Z., Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium. Human Gene Therapy 2007 18 8 746 752 2-s2.0-34548490545 10.1089/hum.2007.053 (Pubitemid 47378071)
114. Fu Y. H., He J. S., Wang X. B., Zheng X.-X., Wu Q., Xie C., Zhang M., Wei W., Tang Q., Song J.-D., Qu J.-G., Hong T., A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus. Biochemical and Biophysical Research Communications 2010 395 1 87 92 2-s2.0-77951892222 10.1016/j.bbrc.2010.03.144
115. Elliott M. B., Chen T., Terio N. B., Chong S.-Y., Abdullah R., Luckay A., Egan M. A., Boutilier L. A., Melville K., Lerch R. A., Long D., Eldridge J. H., Parks C. L., Udem S. A., Hancock G. E., Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques. Vaccine 2007 25 41 7132 7144 2-s2.0-34648820311 10.1016/j.vaccine.2007.07.065 (Pubitemid 47464675)
116. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H., Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 1969 89 4 422 434 2-s2.0-0014495251
117. Openshaw P. J. M., Tregoning J. S., Immune responses and disease enhancement during respiratory syncytial virus infection. Clinical Microbiology Reviews 2005 18 3 541 555 2-s2.0-22244473286 10.1128/CMR.18.3.541-555.2005 (Pubitemid 40995115)
118. Valarcher J. F., Taylor G., Bovine respiratory syncytial virus infection. Veterinary Research 2007 38 2 153 180 2-s2.0-34147098906 10.1051/vetres:2006053 (Pubitemid 46557872)
119. van Drunen Littel-van den Hurk S., Mapletoft J. W., Arsic N., Kovacs-Nolan J., Immunopathology of RSV infection: prospects for developing vaccines without this complication. Reviews in Medical Virology 2007 17 1 5 34 2-s2.0-33846270721 10.1002/rmv.518 (Pubitemid 46115872)
120. Singh S. R., Dennis V. A., Carter C. L., Pillai S. R., Jefferson A., Sahi S. V., Moore E. G., Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model. Vaccine 2007 25 33 6211 6223 2-s2.0-34447635714 10.1016/j.vaccine.2007.05.068 (Pubitemid 47088037)
121. Subbarayan P., Qin H., Pillai S., Lee J. J., Pfendt A. P., Willing G., Miller M. E., Dennis V. A., Singh S. R., Expression and characterization of a multivalent human respiratory syncytial virus protein. Molekuliarnaia Biologiia 2010 44 3 477 487 2-s2.0-77956289548
122. Murawski M. R., McGinnes L. W., Finberg R. W., Kurt-Jones E. A., Massare M. J., Smith G., Heaton P. M., Fraire A. E., Morrison T. G., Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. Journal of Virology 2010 84 2 1110 1123 2-s2.0-73849146459 10.1128/JVI.01709-09
123. Takimoto T., Hurwitz J. L., Coleclough C., Prouser C., Krishnamurthy S., Zhan X., Boyd K., Scroggs R. A., Brown B., Nagai Y., Portner A., Slobod K. S., Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. Journal of Virology 2004 78 11 6043 6047 2-s2.0-2442695260 10.1128/JVI.78.11.6043-6047.2004 (Pubitemid 38661692)
124. Jones B. G., Sealy R. E., Rudraraju R., Traina-Dorge V. L., Finneyfrock B., Cook A., Takimoto T., Portner A., Hurwitz J. L., Sendai virus-based RSV vaccine protects African green monkeys from RSV infection. Vaccine 2012 30 5 959 968 2-s2.0-84855446981 10.1016/j.vaccine.2011.11.046
125. Ward T. M., Traina-Dorge V., Davis K. A., Gray W. L., Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic. Journal of General Virology 2008 89 3 741 750 2-s2.0-42449133486 10.1099/vir.0.83453-0
126. Chen M., Hu K.-F., Rozell B., Örvell C., Morein B., Liljeström P., Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus. Journal of Immunology 2002 169 6 3208 3216 2-s2.0-0037105524 (Pubitemid 35013167)
127. Boyoglu S., Vig K., Pillai S., Rangari V., Dennis V. A., Khazi F., Singh S. R., Enhanced delivery and expression of a nanoencapsulated DNA vaccine vector for respiratory syncytial virus. Nanomedicine 2009 5 4 463 472 2-s2.0-70749118334 10.1016/j.nano.2009.02.004
128. Barnum S. B., Subbarayan P., Vig K., Nano-Encapsulated DNA and/or protein boost immunizations increase efficiency of DNA vaccine protection against RSV. Journal of Nanomedicine and Nanotechnology 2012 3, article 312
129. Eroglu E., Tiwari P. M., Waffo A. B., A nonviral pHEMA+chitosan nanosphere-mediated high-efficiency gene delivery system. International Journal of Nanomedicine 2013 8 1403 1415
130. Roux X., Dubuquoy C., Durand G., Tran-Tolla T.-L., Castagné N., Bernard J., Petit-Camurdan A., Eléouët J.-F., Riffault S., Sub-nucloecapsid nanoparticles: a nasal vaccine against respiratory syncytial virus. PLoS ONE 2008 3 3 2-s2.0-46149087536 10.1371/journal.pone.0001766 e1766 (Pubitemid 351903294)
131. Lindell D. M., Morris S. B., White M. P., Kallal L. E., Lundy P. K., Hamouda T., Baker J. R. Jr., Lukacs N. W., A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without TH2 associated Vaccine-Enhanced disease. PLoS ONE 2011 6 7 2-s2.0-79960319416 10.1371/journal.pone.0021823 e21823
132. Smith G., Raghunandan R., Wu Y., Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats. PLoS ONE 2012 7 11 e50852
133. Glenn G. M., Smith G., Fries L., Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle. Vaccine 2013 31 3 524 532
134. Ferolla F. M., Hijano D. R., Acosta P. L., Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children. American Journal of Respiratory and Critical Care Medicine 2013 187 9 983 990
135. Zang N., Xie X., Deng Y., Wu S., Wang L., Peng C., Li S., Ni K., Luo Y., Liu E., Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice. Journal of Virology 2011 85 24 13061 13068 2-s2.0-84855832111 10.1128/JVI.05869-11
136. Xie X. H., Zang N., Li S. M., Wang L. J., Deng Y., He Y., Yang X.-Q., Liu E.-M., Reseveratrol inhibits respiratory syncytial virus-induced IL-6 production, decreases virla replication, and downregulates TRIF expression in airway epithelial cells. Inflammation 2012 35 4 1392 1401 2-s2.0-84857671057 10.1007/s10753-012-9452-7
137. Belderbos M. E., Houben M. L., Wilbrink B., Lentjes E., Bloemen E. M., Kimpen J. L. L., Rovers M., Bont L., Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 2011 127 6 e1513 e1520 2-s2.0-79957891834 10.1542/peds.2010-3054
138. Hansdottir S., Monick M. M., Lovan N., Powers L., Gerke A., Hunninghake G. W., Vitamin D decreases respiratory syncytial virus induction of NF- B-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. Journal of Immunology 2010 184 2 965 974 2-s2.0-76249105902 10.4049/jimmunol.0902840
139. Al-Sonboli N., Al-Aghbari N., Al-Aryani A., Atef Z., Brabin B., Shenkin A., Roberts E., Harper G., Hart C. A., Cuevas L. E., Micronutrient concentrations in respiratory syncytial virus and human metapneumovirus in yemeni children. Annals of Tropical Paediatrics 2009 29 1 35 40 2-s2.0-63849281665 10.1179/146532809X402015
140. Dowell S. F., Papic Z., Bresee J. S., Larrañaga C., Mendez M., Sowell A. L., Gary H. E. Jr., Anderson L. J., Avendaño L. F., Treatment of respiratory syncytial virus infection with vitamin A: a randomized, placebo-controlled trial in Santiago, Chile. The Pediatric Infectious Disease Journal 1996 15 9 782 786 2-s2.0-0029808370 10.1097/00006454-199609000-00009 (Pubitemid 26304452)
141. Chiba E., Tomosada Y., Vizoso-Pinto M. G., Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection. International Immunopharmacology 2013 17 2 373 382
142. Wu J. Z., Lin C. C., Hong Z., Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design. Journal of Antimicrobial Chemotherapy 2003 52 4 543 546 2-s2.0-0141928585 10.1093/jac/dkg405 (Pubitemid 37258410)
143. Gish R. G., Treating HCV with ribavirin analogues and ribavirin-like molecules. Journal of Antimicrobial Chemotherapy 2006 57 1 8 13 2-s2.0-30344455618 10.1093/jac/dki405 (Pubitemid 43057053)
144. Langhans B., Nischalke H. D., Arndt S., Ribavirin exerts differential effects on functions of CD4+Th1, Th2, and regulatory T cell clones in hepatitis C. PLoS ONE 2012 7 7 e42094
145. Markland W., Mcquaid T. J., Jain J., Kwong A. D., Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX- 497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrobial Agents and Chemotherapy 2000 44 4 859 866 2-s2.0-0034102651 10.1128/AAC.44.4.859-866.2000 (Pubitemid 30165261)
146. Chapman J., Abbott E., Alber D. G., Baxter R. C., Bithell S. K., Henderson E. A., Carter M. C., Chambers P., Chubb A., Cockerill G. S., Collins P. L., Dowdell V. C. L., Keegan S. J., Kelsey R. D., Lockyer M. J., Luongo C., Najarro P., Pickles R. J., Simmonds M., Taylor D., Tyms S., Wilson L. J., Powell K. L., RSV604, a novel inhibitor of respiratory syncytial virus replication. Antimicrobial Agents and Chemotherapy 2007 51 9 3346 3353 2-s2.0-35948949782 10.1128/AAC.00211-07 (Pubitemid 350067550)
147. Ni L., Zhao L., Qian Y., Zhu J., Jin Z., Chen Y. W., Tien P., Gao G. F., Design and characterization of human respiratory syncytial virus entry inhibitors. Antiviral Therapy 2005 10 7 833 840 2-s2.0-27844511949 (Pubitemid 41652977)
148. Pastey M. K., Gower T. L., Spearman P. W., Crowe J. E. Jr., Graham B. S., A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nature Medicine 2000 6 1 35 40 2-s2.0-0033963230 10.1038/71503 (Pubitemid 30048523)
149. Wang X. A., Cianci C. W., Yu K. L., Combrink K. D., Thuring J. W., Zhang Y., Civiello R. L., Kadow K. F., Roach J., Li Z., Langley D. R., Krystal M., Meanwell N. A., Respiratory syncytial virus fusion inhibitors. Part 5: optimization of benzimidazole substitution patterns towards derivatives with improved activity. Bioorganic and Medicinal Chemistry Letters 2007 17 16 4592 4598 2-s2.0-34447310013 10.1016/j.bmcl.2007.05.102 (Pubitemid 47058940)
150. Nikitenko A. A., Raifeld Y. E., Wang T. Z., The discovery of RFI-641 as a potent and selective inhibitor of the respiratory syncytial virus. Bioorganic and Medicinal Chemistry Letters 2001 11 8 1041 1044 2-s2.0-0035938427 10.1016/S0960-894X(01)00150-0 (Pubitemid 32319976)
151. Sun L., Singh A. K., Vig K., Pillai S. R., Singh S. R., Silver nanoparticles inhibit replication of respiratory syncytial virus. Journal of Biomedical Nanotechnology 2008 4 2 149 158 2-s2.0-58149083893 10.1166/jbn.2008.012
152. Singh S. R., Tiwari P. M., Dennis V. A., Anti-respiratory syncytial virus peptide functionalized gold nanoparticles. US Patent Office, 2012
153. Alvarez R., Elbashir S., Borland T., Toudjarska I., Hadwiger P., John M., Roehl I., Morskaya S. S., Martinello R., Kahn J., Van Ranst M., Tripp R. A., DeVincenzo J. P., Pandey R., Maier M., Nechev L., Manoharan M., Kotelianski V., Meyers R., RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrobial Agents and Chemotherapy 2009 53 9 3952 3962 2-s2.0-70349147840 10.1128/AAC.00014-09
154. DeVincenzo J., Cehelsky J. E., Alvarez R., Elbashir S., Harborth J., Toudjarska I., Nechev L., Murugaiah V., Vliet A. V., Vaishnaw A. K., Meyers R., Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral Research 2008 77 3 225 231 2-s2.0-38749136602 10.1016/j.antiviral.2007.11.009
155. DeVincenzo J., Lambkin-Williams R., Wilkinson T., Cehelsky J., Nochur S., Walsh E., Meyers R., Gollob J., Vaishnaw A., A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proceedings of the National Academy of Sciences of the United States of America 2010 107 19 8800 8805 2-s2.0-77952688315 10.1073/pnas. 0912186107
156. Zamora M. R., Budev M., Rolfe M., Gottlieb J., Humar A., DeVincenzo J., Vaishnaw A., Cehelsky J., Albert G., Nochur S., Gollob J. A., Glanville A. R., RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. American Journal of Respiratory and Critical Care Medicine 2011 183 4 531 538 2-s2.0-79951849229 10.1164/rccm.201003-0422OC
157. Summerton J., Weller D., Morpholino antisense oligomers: design, preparation, and properties. Antisense and Nucleic Acid Drug Development 1997 7 3 187 195 2-s2.0-0030862707 (Pubitemid 27323077)
158. Wang K. C., Chang J. S., Chiang L. C., Lin C.-C., Sheng-Ma-Ge-Gen-Tang (Shoma-kakkon-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract. Journal of Ethnopharmacology 2011 135 2 538 544 2-s2.0-79955703075 10.1016/j.jep.2011.03.058
159. Wang K. C., Chang J. S., Chiang L. C., Lin C. C., Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines. The American Journal of Chinese Medicine 2012 40 1 151 162 2-s2.0-84856635484 10.1142/S0192415X12500127
160. Chang J. S., Yeh C. F., Wang K. C., Shieh D. E., Yen M. H., Chiang L. C., Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract. Journal of Ethnopharmacology 2013 147 2 481 487
161. Chang J. S., Wang K. C., Yeh C. F., Shieh D. E., Chiang L. C., Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. Journal of Ethnopharmacology 2013 145 1 146 151
162. Chang J. S., Wang K. C., Shieh D. E., Hsu F. F., Chiang L. C., Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. Journal of Ethnopharmacology 2012 139 1 305 310 2-s2.0-83555165216 10.1016/j.jep.2011.11.018
163. Yeh C. F., Chang J. S., Wang K. C., Shieh D. E., Chiang L. C., Water extract of Cinnamomum cassia Blume inhibited human respiratory syncytial virus by preventing viral attachment, internalization, and syncytium formation. Journal of Ethnopharmacology 2013 147 2 321 326
164. Li L., Yu C. H., Ying H. Z., Yu J. M., Antiviral effects of modified Dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model. Journal of Ethnopharmacology 2013 147 1 238 244
165. Connor J. H., McKenzie M. O., Parks G. D., Lyles D. S., Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses. Virology 2007 362 1 109 119 2-s2.0-34247191488 10.1016/j.virol.2006.12.026 (Pubitemid 46617696)
166. Geller R., Andino R., Frydman J., Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus. PLoS ONE 2013 8 2 e56762
167. Wild C., Greenwell T., Matthews T., A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Research and Human Retroviruses 1993 9 11 1051 1053 2-s2.0-0027692502
168. Wang E., Sun X., Qian Y., Zhao L., Tien P., Gao G. F., Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion. Biochemical and Biophysical Research Communications 2003 302 3 469 475 2-s2.0-0345701489 10.1016/S0006-291X(03)00197-9 (Pubitemid 36279552)
169. Bossart K. N., Mungall B. A., Crameri G., Wang L. F., Eaton B. T., Broder C. C., Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein. Virology Journal 2005 2, article 57 2-s2.0-24944483017 10.1186/1743-422X-2-57 (Pubitemid 41321177)
170. Porotto M., Doctor L., Carta P., Fornabaio M., Greengard O., Kellogg G. E., Moscona A., Inhibition of Hendra virus fusion. Journal of Virology 2006 80 19 9837 9849 2-s2.0-33748948794 10.1128/JVI.00736-06 (Pubitemid 44435658)
171. Porotto M., Carta P., Deng Y., Kellogg G. E., Whitt M., Lu M., Mungall B. A., Moscona A., Molecular determinants of antiviral potency of paramyxovirus entry inhibitors. Journal of Virology 2007 81 19 10567 10574 2-s2.0-34648830863 10.1128/JVI.01181-07 (Pubitemid 47463330)
172. Porotto M., Rockx B., Yokoyama C. C., Talekar A., DeVito I., Palermo L. M., Liu J., Cortese R., Lu M., Feldmann H., Pessi A., Moscona A., Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry. PLoS Pathogens 2010 6 10 2-s2.0-78449243403 10.1371/journal.ppat.1001168 e1001168
173. Deffrasnes C., Hamelin M.-È., Prince G. A., Boivin G., Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus. Antimicrobial Agents and Chemotherapy 2008 52 1 279 287 2-s2.0-37849034056 10.1128/AAC.00793-07
174. Lambert D. M., Barney S., Lambert A. L., Guthrie K., Medinas R., Davis D. E., Bucy T., Erickson J., Merutka G., Petteway S. R. Jr., Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proceedings of the National Academy of Sciences of the United States of America 1996 93 5 2186 2191 2-s2.0-9044234408 10.1073/pnas.93.5.2186 (Pubitemid 26079903)
175. Andries K., Moeremans M., Gevers T., Willebrords R., Sommen C., Lacrampe J., Janssens F., Wyde P. R., Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus. Antiviral Research 2003 60 3 209 219 2-s2.0-0345447465 10.1016/j.antiviral.2003.07.004 (Pubitemid 37456869)
176. Lundin A., Bergström T., Bendrioua L., Kann N., Adamiak B., Trybala E., Two novel fusion inhibitors of human respiratory syncytial virus. Antiviral Research 2010 88 3 317 324 2-s2.0-78650245710 10.1016/j.antiviral.2010.10.004
177. Yu K. L., Zhang Y., Civiello R. L., Kadow K. F., Cianci C., Krystal M., Meanwell N. A., Fundamental structure-activity relationships associated with a new structural class of respiratory syncytial virus inhibitor. Bioorganic and Medicinal Chemistry Letters 2003 13 13 2141 2144 2-s2.0-0037871897 10.1016/S0960-894X(03)00383-4 (Pubitemid 36694292)
178. Yu K. L., Zhang Y., Civiello R. L., Trehan A. K., Pearce B. C., Yin Z., Combrink K. D., Gulgeze H. B., Wang X. A., Kadow K. F., Cianci C. W., Krystal M., Meanwell N. A., Respiratory syncytial virus inhibitors. Part 2: benzimidazol-2-one derivatives. Bioorganic and Medicinal Chemistry Letters 2004 14 5 1133 1137 2-s2.0-10744230814 10.1016/j.bmcl.2003.12.072 (Pubitemid 38229842)
179. Yu K. L., Wang X. A., Civiello R. L., Trehan A. K., Pearce B. C., Yin Z., Combrink K. D., Gulgeze H. B., Zhang Y., Kadow K. F., Cianci C. W., Clarke J., Genovesi E. V., Medina I., Lamb L., Wyde P. R., Krystal M., Meanwell N. A., Respiratory syncytial virus fusion inhibitors. Part 3: water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo. Bioorganic and Medicinal Chemistry Letters 2006 16 5 1115 1122 2-s2.0-31344453015 10.1016/j.bmcl.2005.11.109 (Pubitemid 43142973)
180. Combrink K. D., Gulgeze H. B., Thuring J. W., Yu K.-L., Civiello R. L., Zhang Y., Pearce B. C., Yin Z., Langley D. R., Kadow K. F., Cianci C. W., Li Z., Clarke J., Genovesi E. V., Medina I., Lamb L., Yang Z., Zadjura L., Krystal M., Meanwell N. A., Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety. Bioorganic and Medicinal Chemistry Letters 2007 17 17 4784 4790 2-s2.0-34547511172 10.1016/j.bmcl.2007.06.065 (Pubitemid 47187713)
181. Sin N., Venables B. L., Combrink K. D., Gulgeze H. B., Yu K.-L., Civiello R. L., Thuring J., Wang X. A., Yang Z., Zadjura L., Marino A., Kadow K. F., Cianci C. W., Clarke J., Genovesi E. V., Medina I., Lamb L., Krystal M., Meanwell N. A., Respiratory syncytial virus fusion inhibitors. Part 7: structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo. Bioorganic and Medicinal Chemistry Letters 2009 19 16 4857 4862 2-s2.0-67651102834 10.1016/j.bmcl.2009.06.030
182. Nikitenko A., Raifeld Y., Mitsner B., Newman H., Pyrimidine containing RSV fusion inhibitors. Bioorganic and Medicinal Chemistry Letters 2005 15 2 427 430 2-s2.0-10644297146 10.1016/j.bmcl.2004.10.056 (Pubitemid 39647162)
183. Pryde D. C., Tran T. D., Gardner I., Non-benzimidazole containing inhibitors of respiratory syncytial virus. Bioorganic and Medicinal Chemistry Letters 2013 23 3 827 833
184. Galdiero S., Falanga A., Vitiello M., Cantisani M., Marra V., Galdiero M., Silver nanoparticles as potential antiviral agents. Molecules 2011 16 10 8894 8918 2-s2.0-80054958479 10.3390/molecules16108894
185. Tiwari P. M., Vig K., Dennis V. A., Singh S. R., Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011 1 1 31 63
186. Vardharajula S., Ali S. Z., Tiwari P. M., Functionalized carbon nanotubes: biomedical applications. International Journal of Nanomedicine 2012 7 5361 5374
187. Stone J. W., Thornburg N. J., Blum D. L., Kuhn S. J., Wright D. W., Crowe J. E. Jr., Gold nanorod vaccine for respiratory syncytial virus. Nanotechnology 2013 24 29 295102
188. Lee N. S., Dohjima T., Bauer G., Li H., Li M.-J., Ehsani A., Salvaterra P., Rossi J., Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnology 2002 20 5 500 505 2-s2.0-0036256430 10.1038/nbt0502-500 (Pubitemid 34495938)
189. Barik S., Control of nonsegmented negative-strand RNA virus replication by siRNA. Virus Research 2004 102 1 27 35 2-s2.0-1842531651 10.1016/j.virusres. 2004.01.012 (Pubitemid 38447246)
190. Zhang Y. L., Cheng T., Cai Y. J., RNA interference inhibits hepatitis B virus of different genotypes in vitro and in vivo. BMC Microbiology 2010 10, article 214
191. Jairath S., Brown Vargas P., Hamlin H. A., Field A. K., Kilkuskie R. E., Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides. Antiviral Research 1997 33 3 201 213 2-s2.0-0031036222 10.1016/S0166-3542(96)01015-7 (Pubitemid 27060367)
192. Bitko V., Musiyenko A., Shulyayeva O., Barik S., Inhibition of respiratory viruses by nasally administered siRNA. Nature Medicine 2005 11 1 50 55 2-s2.0-13444262170 10.1038/nm1164 (Pubitemid 40215837)
193. Bitko V., Barik S., Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiology 2001 1, article 34 2-s2.0-19044381013
194. Vig K., Lewis N., Moore E. G., Pillai S., Dennis V. A., Singh S. R., Secondary RNA structure and its role in RNA interference to silence the respiratory syncytial virus fusion protein gene. Molecular Biotechnology 2009 43 3 200 211 2-s2.0-70350569351 10.1007/s12033-009-9190-8
195. Kumar M., Mohapatra S. S., Behera A. K., Lockey R. F., Zhang J., Bhullar G., Perez de la Cruz C., Chen L.-C., Leong K. W., Huang S.-K., Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Human Gene Therapy 2002 13 12 1415 1425 2-s2.0-0036382826 10.1089/10430340260185058
196. Zhang W., Yang H., Kong X., Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nature Medicine 2005 11 1 56 62 (Pubitemid 40215838)
197. Dong B., Silverman R. H., 2-5A-dependent RNase molecules dimerize during activation by 2-5A. The Journal of Biological Chemistry 1995 270 8 4133 4137 2-s2.0-0028909072 10.1074/jbc.270.8.4133
198. Cirino N. M., Li G., Xiao W., Torrence P. F., Silverman R. H., Targeting RNA decay with 2′5′ oligoadenylate-antisense in respiratory syncytial virus-infected cells. Proceedings of the National Academy of Sciences of the United States of America 1997 94 5 1937 1942 2-s2.0-0031042434
199. Barnard D. L., Sidwell R. W., Xiao W., Player M. R., Adah S. A., Torrence P. F., 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection. Antiviral Research 1999 41 3 119 134 2-s2.0-0033010079 10.1016/S0166-3542(99)00005-4 (Pubitemid 29146124)
200. Player M. R., Barnard D. L., Torrence P. F., Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA. Proceedings of the National Academy of Sciences of the United States of America 1998 95 15 8874 8879 2-s2.0-0032555288
201. Xu Z., Kuang M., Okicki J. R., Cramer H., Chaudhary N., Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin. Antiviral Research 2004 61 3 195 206 2-s2.0-0842332285 10.1016/j.antiviral.2003.10.005 (Pubitemid 38183060)
202. Leaman D. W., Longano F. J., Okicki J. R., Soike K. F., Torrence P. F., Silverman R. H., Cramer H., Targeted therapy of respiratory syncytial virus in African green monkeys by intra nasally administered 2-5A antisense. Virology 2002 292 1 70 77 2-s2.0-0036061381 10.1006/viro.2001.1213
203. Ripple M. J., You D., Honnegowda S., Giaimo J. D., Sewell A. B., Becnel D. M., Cormier S. A., Immunomodulation with IL-4R α antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease. Journal of Immunology 2010 185 8 4804 4811 2-s2.0-78049517831 10.4049/jimmunol.1000484
204. Summerton J., Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochimica et Biophysica Acta 1999 1489 1 141 158 2-s2.0-0032699477 10.1016/S0167-4781(99)00150-5
205. Lai S. H., Stein D. A., Guerrero-Plata A., Liao S.-L., Ivanciuc T., Hong C., Iversen P. L., Casola A., Garofalo R. P., Inhibition of respiratory syncytial virus infections with morpholino oligomers in cell cultures and in mice. Molecular Therapy 2008 16 6 1120 1128 2-s2.0-44349115145 10.1038/mt.2008.81 (Pubitemid 351737078)
206. Ma S. C., Du J., But P. P.-H., Deng X.-L., Zhang Y.-W., Ooi V. E.-C., Xu H.-X., Lee S. H.-S., Lee S. F., Antiviral Chinese medicinal herbs against respiratory syncytial virus. Journal of Ethnopharmacology 2002 79 2 205 211 2-s2.0-0036166889 10.1016/S0378-8741(01)00389-0 (Pubitemid 34136952)
207. Vaidya R., Observational therapeutics: scope, challenges, and organization. Journal of Ayurveda and Integrative Medicine 2011 2 4 165 169 2-s2.0-84855222263 10.4103/0975-9476.90764
208. Ojwang J. O., Wang Y. H., Wyde P. R., Fischer N. H., Schuehly W., Appleman J. R., Hinds S., Shimasaki C. D., A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals. Antiviral Research 2005 68 3 163 172 2-s2.0-27744529166 10.1016/j.antiviral.2005.09.003 (Pubitemid 41612461)
209. Chung D. H., Moore B., Matharu D., A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus. Virology Journal 2013 10, article 19
210. Power U. F., Respiratory syncytial virus (RSV) vaccines-two steps back for one leap forward. Journal of Clinical Virology 2008 41 1 38 44 2-s2.0-37349028337 10.1016/j.jcv.2007.10.024 (Pubitemid 350298980)
211. Papin J. F., Wolf R. F., Kosanke S. D., Infant Baboons infected with respiratory syncytial virus develop clinical and pathologic changes that parallel those of human infants. American Journal of Physiology-Lung Cellular and Molecular Physiology 2013 304 8 L530 L539
212. Graham B. S., Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunological Reviews 2011 239 1 149 166 2-s2.0-78650566298 10.1111/j.1600-065X.2010.00972.x
213. Stockman L. J., Brooks W. A., Streatfield P. K., Challenges to evaluating respiratory syncytial virus mortality in Bangladesh, 2004-2008. PLoS ONE 2013 8 1 e53857
214. Harada Y., Kinoshita F., Yoshida L. M., Does respiratory virus co-infection increase the clinical severity of acute respiratory infection among children infected with respiratory syncytial virus? The Pediatric Infectious Disease Journal 2013 32 5 441 445 10.1097/INF.0b013e31828ba08c
215. Bosch A. A. T. M., Biesbroek G., Trzcinski K., Sanders E. A. M., Bogaert D., Viral and bacterial interactions in the upper respiratory tract. PLoS Pathogens 2013 9 1 e1003057
216. Holt P. G., Sly P. D., Interactions between RSV infection, asthma, and atopy: unraveling the complexities. The Journal of Experimental Medicine 2002 196 10 1271 1275 2-s2.0-0037131978 10.1084/jem.20021572 (Pubitemid 35375547)
217. Han J., Takeda K., Gelfand E. W., The role of RSV infection in asthma initiation and progression: findings in a mouse model. Pulmonary Medicine 2011 2011 8 748038 10.1155/2011/748038
218. Szabo S. M., Levy A. R., Gooch K. L., Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy. Paediatric Respiratory Reviews 2013 13 2 70161 70166
219. Tapia L. I., Ampuero S., Palomino M. A., Respiratory syncytial virus infection and recurrent wheezing in Chilean infants: a genetic background? Infection, Genetics and Evolution 2013 16 0 54 61
220. Thomsen S. F., van der Sluis S., Stensballe L. G., Posthuma D., Skytthe A., Kyvik K. O., Duffy D. L., Backer V., Bisgaard H., Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. American Journal of Respiratory and Critical Care Medicine 2009 179 12 1091 1097 2-s2.0-67449100135 10.1164/rccm.200809-1471OC
221. Vandini S., Corvaglia L., Alessandroni R., Respiratory syncytial virus infection in infants and correlation with meteorological factors and air pollutants. Italian Journal of Pediatrics 2013 39, article 1
222. Iwane M. K., Chaves S. S., Szilagyi P. G., Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US Counties-2002-2009. American Journal of Epidemiology 2013 177 7 656 665
223. El Kholy A. A., Mostafa N. A., El-Sherbini S. A., Morbidity and outcome of severe respiratory syncytial virus infection. Pediatrics International 2013 14 10 283 288
224. Welliver R. C. Sr., Temperature, humidity, and ultraviolet B radiation predict community respiratory syncytial virus activity. The Pediatric Infectious Disease Journal 2007 26 supplement 11 S29 S35 2-s2.0-37349124230 10.1097/INF.0b013e318157da59 (Pubitemid 350295027)